Using Bioptron Light to Treat Carpal Tunnel Syndrome in Pregnant Women
Effect of Bioptron Light Therapy on Pregnancy Related Carpal Tunnel Syndrome
This study is testing if Bioptron light therapy can help pregnant women with carpal tunnel syndrome feel better and improve their hand function.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 62 (estimated) |
| Ages | 25 Years to 35 Years |
| Sex | Female |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza) |
| Trial ID | NCT06209918 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Bioptron light therapy on pregnant women suffering from carpal tunnel syndrome (CTS). CTS is a condition characterized by pain, numbness, and tingling in the hand due to median nerve compression. In this randomized controlled trial, 62 women will be divided into two groups: one receiving Bioptron light therapy along with patient education, and the other receiving only educational advice. The therapy sessions will last 10 minutes each, three times a week for four weeks, aiming to reduce symptoms and improve hand function.
Who should consider this trial
Good fit: Ideal candidates are pregnant women aged 25-35 with a clinical diagnosis of carpal tunnel syndrome for at least one month.
Not a fit: Patients with a history of neurological diseases, hand surgery, or other specified medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive and effective option for managing carpal tunnel syndrome during pregnancy.
How similar studies have performed: While the use of light therapy for various conditions has shown promise, this specific application for pregnancy-related carpal tunnel syndrome is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant females clinically daignosed with carpal tunnel syndrome at least 1 month * age will range from (25-35) years. * body mass index (BMI) will be (BMI ≤ 35 kg/m2) Exclusion Criteria: * history of neurologic disease * hand surgery * hand trauma, * diabetes mellitus * cervical spondylosis * osteoarthritis of cervical spine and wrist joint * chronic renal failure * heart failure * connective tissue disorders
Where this trial is running
Giza
- Sara Magdy Ahmed — Giza, Egypt (Recruiting)
Study contacts
- Principal investigator: Sara Ma Ahmed, lecturer — Cairo University
- Study coordinator: Sara Ma Ahmed, lecturer
- Email: saramagdy87@cu.edu.eg
- Phone: 01063998331
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.